Most just lately, it's been identified that conolidine and the above derivatives act around the atypical chemokine receptor 3 (ACKR3. Expressed in identical spots as classical opioid receptors, it binds to the big selection of endogenous opioids. Not like most opioid receptors, this receptor functions being a scavenger and doesn't activate a next m